Comparative Analysis for the Patellar Bony Defect Using by Autogenous Bone: Patellar Tendon - Bone ACL Reconstruction - Donor Site Morbidity & Morphological Change Between the Group of Non - replaced Bony Defect and the Group of Replaced Bony Defect Using.
- Author:
Dong Min SHIN
;
Sang Ho HA
;
Hong Moon SOHN
- Publication Type:Original Article
- Keywords:
Bone - patellar tendon - bone graft;
Donor site morbidity
- MeSH:
Anterior Cruciate Ligament Reconstruction;
Bone-Patellar Tendon-Bone Grafts;
Follow-Up Studies;
Heterografts*;
Humans;
Knee;
Patella;
Patellar Ligament*;
Pectinidae;
Tendinopathy;
Tissue Donors*;
Transplants
- From:Journal of the Korean Knee Society
1997;9(1):19-22
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Arthroscopic anterior cruciate ligament reconstruction with bone-patella tendon-bone has been commonly using for ACL insufficient patients. Bone-patellar tendon-bone graft is a strong intra-articular substitute, which allows, by means of its bony end, a rigid fixation with early bone to hone healing. As a counterpart, potentially serious cornplications & donor site morbidity has been reported, such as patella fracture & patella tendon avulsion, anterior knee pain, patella tendinitis, dcmor site pain and bone defect. We suppose tightly packing the donor site bony defect with hetrograft (Lubboc) may be also useful. So, we analyzed the morphological change in bony defect and donor site morbidity between the group of non-replaced bony defect and the group of replaced bony defect using by heterograft (Lubboc). We replaceJ hetrograft into the patellar side bony defect in 15 knees and left alone in l5 knees. The average follow up period was 17 months. The results werc as follows: 1. Nearly norma1 appearance on the bony defect showed at the long tenn follow up roentgenogram in the group of replaced hetrograft, but scalloping on the pateltar bomp defect was seen in non-replaced group. 2. Donor site morbidity (pain or patellai tendinitis) was developed 8 knees in the replaced group, and 7 knees in the non-rep)aced group. 3. We conclude that the filled in the bony defect hy hone graft (heterografl:) can not decrease the donor site morbidi ty.
